Nitroglycerin Tablet

Free

Product Composition & Available Strengths

We supply Nitroglycerin Sublingual Tablets in exact, internationally calibrated low-dose strengths to allow for immediate rescue titration during acute ischemic episodes.

Active Ingredient Common NameCompendial TitleAvailable StrengthsPrimary Clinical Target
Nitroglycerin (GTN)Glyceryl Trinitrate IP / BP / USP0.4 mgStandard Rescue Dose: Preferred international standard for immediate acute angina abortion.
Nitroglycerin (GTN)Glyceryl Trinitrate IP / BP / USP0.5 mgHigh-Threshold Prophylaxis: Calibrated for heavy coronary spasm management or pre-exertion protection.
Categories: , Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Nitroglycerin Tablet

Nitroglycerin (Glyceryl Trinitrate) Sublingual Tablets

Healthy Life Pharma Private Limited, alongside our specialized global export and marketing division Healthy Inc, is a leading Indian manufacturer, CDMO services provider, and wholesale supplier of advanced cardiovascular, critical care, and emergency medicine therapeutics. We manufacture ultra-high-purity, kinetically stable Nitroglycerin (Glyceryl Trinitrate) Sublingual Tablets within our WHO–GMP certified, climate-controlled solid dosage manufacturing installations. This essential emergency coronary vasodilator serves as a high-frequency strategic export to emergency hospital networks, institutional tenders, national defense procurement programs, and global B2B wholesale marketplaces across Africa, the CIS region, LATAM, and Southeast Asia.

Product Overview

This formulation operates as an “Immediate Endothelial Smooth Muscle Relaxant.” It ensures patient safety during an acute ischemic crisis by bypassing the gastrointestinal tract completely, establishing rapid plasma saturation within 1 to 3 minutes of placement.

  • Mechanism 1 (Systemic Bioavailability Optimization): Swallowed nitroglycerin undergoes near-total (greater than 95%) chemical degradation via hepatic first-pass metabolism. Our sublingual matrix allows the drug to physically dissolve under the tongue, absorbing directly across the sublingual mucosa into the superior vena cava, delivering instant cardiac bioavailability.

  • Mechanism 2 (Nitric Oxide Vasodilation Cascade): Once in the bloodstream, the active molecule is chemically converted into Nitric Oxide (NO). Nitric oxide activates vascular guanylate cyclase, increasing intracellular cyclic GMP ($cGMP$) levels. This physically forces the dephosphorylation of myosin light chains, inducing profound smooth muscle relaxation.

  • Mechanism 3 (Cardiac Preload Reduction): Broad venous vasodilation physically increases venous pooling, dropping venous return pressure (preload). This chemically lowers total myocardial wall tension and oxygen demand while physically expanding coronary collateral vessels to restore blood flow to ischemic myocardium.

Product Composition & Available Strengths

We supply Nitroglycerin Sublingual Tablets in exact, internationally calibrated low-dose strengths to allow for immediate rescue titration during acute ischemic episodes.

Active Ingredient Common NameCompendial TitleAvailable StrengthsPrimary Clinical Target
Nitroglycerin (GTN)Glyceryl Trinitrate IP / BP / USP0.4 mgStandard Rescue Dose: Preferred international standard for immediate acute angina abortion.
Nitroglycerin (GTN)Glyceryl Trinitrate IP / BP / USP0.5 mgHigh-Threshold Prophylaxis: Calibrated for heavy coronary spasm management or pre-exertion protection.

Technical & Logistics Specifications

  • HS Code: 3004.90.99 (Medicaments acting on the cardiovascular system / Organic Nitrates)

  • CAS Number: 55-63-0 (Glyceryl Trinitrate)

  • Dosage Form: Sublingual Oral Tablet (Molded or compressed matrix engineered for rapid sublingual mucosal disintegration)

  • Packaging Configurations: 25 or 50 Tablets per Hermetically Sealed Amber Glass Bottle capped with a tight metal induction-sealed closure, or specialized high-barrier Alu-Alu blister configurations.

Crucial Sublingual Stability & Packing Protocols

Partner Alert on Volatility: Nitroglycerin is a highly volatile chemical compound. It physically migrates out of plastic configurations and evaporates when exposed to open air or moisture, causing the tablets to lose their therapeutic potency.

To overcome this major industry defect, our facilities execute two strict engineering safeguards:

  • Hydrophobic Sublingual Matrix: We synthesize the tablet core using a highly specialized, non-hygroscopic binder matrix. This physically ensures that the tablet remains solid and stable in its container but disintegrates within 10 to 15 seconds once physically placed under the tongue.

  • Hermetic Glass Isolation: For our bulk retail supply, we package tablets exclusively inside U.V.-Shielded Amber Glass Bottles. We avoid standard plastic containers entirely, physically preventing nitroglycerin vaporization and ensuring a stable 24-month shelf life under challenging Zone IVb climatic conditions.

Primary Indications

  • Emergency Cardiology: Immediate acute relief of an ongoing Angina Pectoris Attack (coronary chest pain).

  • Ischemic Prophylaxis: Short-term preventative protection when taken physically 5 to 10 minutes prior to engaging in physical exertion or stressful situations known to trigger angina.

Usage Instructions

  • Administration Position: The patient must physically sit down or lie down immediately prior to taking the dose. Sudden systemic vasodilation physically drops blood pressure, which can cause transient dizziness or fainting (Postural Hypotension).

  • Sublingual Directive: Place exactly one tablet physically under the tongue or in the buccal pouch. Allow it to dissolve naturally. Do not swallow, chew, or crush the tablet, as standard gastrointestinal routing completely destroys the drug’s therapeutic effect.

  • The 5-Minute Emergency Rule: If chest pain is physically not relieved after exactly 5 minutes, a second dose can be administered. A maximum of 3 tablets may be taken within a 15-minute window. If pain persists beyond 15 minutes, it indicates an evolving Acute Myocardial Infarction (Heart Attack), and emergency medical services must be contacted immediately.

Safety Warning: CRITICAL EMERGENCY CORONARY RESCUE THERAPEUTIC. For Immediate Patient Access. Postural Hypotension Warning: Profound systemic vasodilation can cause sudden physical dizziness, throbbing vascular headaches, and reflex tachycardia. Storage Mandate: Keep tablets strictly inside their original amber glass vial; close the cap tightly immediately after every opening to physically prevent active ingredient evaporation. Absolute Contraindication: NEVER CO-ADMINISTER WITH PDE-5 INHIBITORS (Sildenafil, Tadalafil, Vardenafil). Combining nitrates with erectile dysfunction medications chemically forces a catastrophic, irreversible, life-threatening drop in blood pressure.

Global CDMO Services & Wholesale Supply Chain

Healthy Life Pharma Private Limited and Healthy Inc provide complete, internationally validated Third-Party Contract Manufacturing (CDMO Services) and bulk institutional supply for generic Nitroglycerin Sublingual Tablets. Whether you are fulfilling an emergency supply contract for a National Ministry of Defense Tender, stocking state hospital crash carts in the CIS, or injecting high-compliance life-saving lines into an international B2B Pharmaceutical Marketplace, we supply all mandatory compliance documentation (WHO-GMP Certificate, Certificates of Pharmaceutical Product – COPP, Certificates of Analysis – COA, Stability Records, and Complete CTD Format Dossier sets) for rapid entry registration.

Commercial & Bulk Procurement Inquiries:

  • Corporate Head Office: Mumbai, Maharashtra, India

  • Primary Manufacturing Base: Boisar, Maharashtra, India

  • WhatsApp / Direct Call: +91 7710003340

  • Corporate Email: info@healthyinc.co.in